Prolacta in the News
Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition
Prolacta Formula Fortifier Starts Trial For Newborns With Rare Heart Condition
This article was originally published in The Rose Sheet 28 Feb 2017
Executive Summary
Prolacta Bioscience developed human milk-based formula fortifier for full-term infants born with conditions that make them vulnerable to nutrition deficiencies. Pending results from research at 12 US hospitals, the product would roll out commercially in 2018.